Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating temozolomide for brain metastases from melanoma, breast cancer, or non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Metastases of Central Nervous System, Melanoma | Phase 2 | Status: COMPLETED